Sherif Idriss

Sherif Idriss is the CEO of Elastin Biosciences Ltd, a company focused on elastin-preserving therapeutics.12 He is also the Founder of Lübeck Group.4 Idriss has a background in science, having completed an MSc degree.5 He is actively involved in raising capital for Elastin Biosciences and seeking connections in the biotech industry.7

Elastin Biosciences, a spinoff of Longaevus Technologies, is working on breakthrough discoveries in elastin restoration, which has implications for treating elastin-related diseases such as abdominal aortic aneurysm and improving human healthspan.1 Idriss has presented the company's work at events like the Global Investor Forum.6

In addition to his role at Elastin Biosciences, Idriss is a Co-Founder of BiopharmIQ, a company that provides bio/pharma data for business development and investors.3 He has a network of over 500 contacts on LinkedIn and is associated with the University of Lübeck.2